Medical Research
(H120)
990 on File
NORTH AMERICAN NEUROENDOCRINE TUMOR SOCIETY
Financial strength (30%)
92/100
Reliability (20%)
50/100
Effectiveness (25%)
78/100
Impact (25%)
No data yet
CharityAI™ Score
Not yet evaluated
Financial Overview — FY 2024
$1.2M
Total Revenue
$1.3M
Total Expenses
$1.3M
Net Assets
0
Employees
Revenue Sources
Expense Breakdown
Program Expense Ratio
88.9%
Fundraising Efficiency
N/A
Operating Reserve
11.91x
Liability-to-Asset
12.5%
Revenue Diversification
77.7%
Compared with Peers
FY 2024
Compared with 332 similar organizations
(United States, Medical Research, $1M–$10M in expenses), FY 2024.
This organization
Middle half of peers (P25–P75)
Peer median
| Ratio | This org | Peer median | Position (P10 → P90) | |
|---|---|---|---|---|
|
Program expense ratio
Program expenses / total expenses
· higher is better
|
88.9% | 83.0% |
P10P90
|
Above median |
|
Admin expense ratio
Management and general / total expenses
· lower is better
|
11.1% | 10.7% |
P10P90
|
Below median |
|
Fundraising expense ratio
Fundraising expenses / total expenses
· lower is better
|
0.0% | 2.0% |
P10P90
|
Top quarter |
|
Operating reserve
Months of expenses covered by net assets
· higher is better
|
11.9 mo | 12.8 mo |
P10P90
|
Below median |
|
Liabilities to assets
Total liabilities / total assets
· lower is better
|
12.5% | 10.1% |
P10P90
|
Below median |
|
Revenue concentration
Share of revenue from the largest source
· lower is better
|
77.7% | 90.7% |
P10P90
|
Above median |
|
Revenue growth
Year over year revenue growth
|
11.0% | 12.5% |
P10P90
|
|
|
Expense growth
Year over year expense growth
|
-5.1% | 11.1% |
P10P90
|
|
|
Surplus margin
Surplus as a share of revenue
|
-7.9% | 2.9% |
P10P90
|
Financial History
| Year | Revenue | Expenses | Net Assets | Program % | Staff |
|---|---|---|---|---|---|
| 2024 | $1.2M | $1.3M | $1.3M | 88.9% | 0 |
| 2023 | $1.1M | $1.4M | $1.4M | 85.6% | 0 |
| 2022 | $1.3M | $1.2M | $1.7M | 90.1% | 0 |
| 2021 | $778K | $490K | N/A | — | 0 |
Donor Reviews
Write a ReviewNo reviews yet
Be the first to share your experience with this organization.